The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks increased across the board for this settlement date.
After the sell-off, there are now many more solid and well-established dividend-paying companies valued at less than 10 times earnings.
Friday’s top analyst upgrades, downgrades and initiations include Aetna, Eli Lilly, Gilead Sciences, Royal Gold and Sirius XM.
The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased across the board for this settlement date.
ThinkstockAre biotech companies going to become the next big companies saddled with debt? Most likely not, but two debt offerings will stand out to investors here. The first was a $10 billion…
Gilead Sciences is going to raise cash via a huge debt offering. Will this cash be used to fund a large buyout? Will it be used for stock and/or debt buybacks?
Jon C. Ogg The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.
24/7 Wall St. has wanted to check on the major stocks in the market with an eagle-eye view of where investors may start to buy stocks, as long as they do not…
The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech stocks backed off for this period.
ThinkstockMost analysts seem to be behind the growth that Gilead Sciences Inc. (NASDAQ: GILD) has seen, namely in its Hepatitis C vaccines (HCV) Harvoni and Solvaldi. For the most part the resulting…
Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet another instance where investors proved that they want to buy stocks after…
courtesy of Gilead SciencesGilead Sciences Inc. (NASDAQ: GILD) reported second-quarter financial results Tuesday after the markets closed. The biotech giant had $3.15 in earnings per share (EPS) on $8.2 billion in revenue…
Chris Lange ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or…
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK)…
Tuesday's top analyst upgrades, downgrades and initiations include Alarm.com, Pandora Media, PayPal, SanDisk, SunEdison, Tesla Motors and Advanced Micro Devices.
